来自MSN20 天
Health Rounds: Experimental drug delays heart valve disease progression, and potentially ...
The most recent 23-patient trial showed a nearly 70% reduction in aortic valve calcification progression at six months compared to placebo. Patients receiving ataciguat tended to maintain better ...
Yahoo Finance1 个月
Multisociety taskforce develops new standards to monitor adults with heart valve disease
(NewMediaWire) - February 17, 2025 - DALLAS The International Consortium for Health Outcomes Measurement (ICHOM) has developed a globally inclusive standard dataset of 16 patient-centered outcome ...
Healio9 天
Q&A: Novel drug may replace ‘watchful waiting’ approach to aortic stenosis care
A novel therapeutic showed significant promise in slowing aortic valve calcification, potentially extending time until or eliminating need for transcatheter or surgical intervention for stenosis, ...